Selective deficit of angiogenic growth factors characterises pregnancies complicated by pre-eclampsia

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 106, Issue 10, 1999, Pages 1019-1022

  Reuvekamp, Alida ^a,b   Velsing Aarts, Francien V ^a,b   Poulina, Indira E J ^a,b   Capello, Jaques J ^a   Duits, Ashley J ^a  

^a CPRLab   (Netherlands)

^b CENTRAL LABORATORY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENIC FACTOR; GROWTH FACTOR;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; NORMAL HUMAN; PLACENTA; PLACENTA DEVELOPMENT; PREECLAMPSIA; PREGNANCY; PRIORITY JOURNAL;

ANGIOGENESIS INDUCING AGENTS; ENDOTHELIAL GROWTH FACTORS; FEMALE; HUMANS; LYMPHOKINES; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY PROTEINS; RETROSPECTIVE STUDIES; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0001475562     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/j.1471-0528.1999.tb08107.x     Document Type: Article

References (32)

1. Dekker GA, Geijn van HP. Endothelial dysfunction in preeclampsia Part 1: Primary prevention. Therapeutic perspectives. J Perinar Med 1996; 24: 99-117.
2. Lie RT, Rasmussen S, Burnborg H, Gjessing HK, Lie-Nielsen E, Irgens LM. Fetal and maternal contributions to risk of pre-eclampsia: population based study. BMJ 1998; 316: 1343-1347.
3. Pijnenborg R, Anthony J, Davey DA, Tiltman A, Vercruysse L, Van Assche A. Placental bed spiral arteries in the hypertensive disorders of pregnancy. Br J Obstet Gynaecol 1991; 98: 648-655.
4. Zhou Y, Damsky CH, Fisher SJ. Preeclampsia is associated with failure of human cytotrophoblasts to mimic a vascular adhesion phenotype. One cause of defective endovascular invasion in this syndrome. J Clin Invest 1997; 99: 2152-2164.
5. Lyall F Greer IA, Boswell F, Macara LM, Walker JJ, Kingdom JCP. The cell adhesion molecule VCAM-I is selectively elevated in serum in pre-eclampsia: does this indicate the mechanism of leukocyte activation Br J Obstet Gynaecol 1994; 101: 485-487.
6. Roberts JM, Edep ME, Goldfein A, Taylor RN. Sera from pre-eclamp tic women specifically activate human umbilical vein endothelial cells in vitro. Am J Reprod lmmunol 1992; 27: 101-108.
7. Vuoral P, Hatva E, Lymboussaki A et al. Expression of vascular endothelial growth factor and placenta growth factor in human placenta. Biol Reprod 1997; 56: 489-494.
8. Luisa Iruela-Arispe M. Normal placentation: A tale that requires an epithelial-to-endothelial conversion. J Clin Invest 1997; 99: 2057-2058.
9. Leung D, Cachianes G, Kuang WJ, Goeddel D, Ferrera N. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 1989; 246: 1306-1309.
10. Poole TJ, Coffin JD. Vasculogenesis and angiogenesis: two distinct morphogenic mechanisms establish embryonic vascular pattern. J Exp Zool 1989; 251: 224-231.
11. Ferrera N, Hounck K, Jakeman L, Leung DW. Molecular and biological properties of the vascular endothelial growth factor family of proteins. Endocr Rev 1992; 13: 18-32.
12. Senger DR, Galli SJ, Dvorak AM, Permzzi CA, Harvey VS, Dvorak HF. Tumor cells secrete a vascular permeability factor which promotes ascites fluid accumulation. Science 1983; 219: 983-985.
13. Shore VH, Wang TH, Wang CL, Tony RJ, Caudle MR, Tony DS. Vascular endothelial growth factor, placenta growth factor and their receptors in isolated human trophoblast. Placenta 1997; 18: 657-665.
14. Lyall F, Young A, Boswell F, Kingdom JCP, Greer IA. Placental expression of vascular endothelial growth factor in placentae from pregnancies complicated by pre-eclampsia and intrauterine growth restriction does not support placental hypoxia at delivery. Placenta 1997; 18: 269-276.
15. Hauser S, Weich HA. A heparin-binding form of placenta growth factor (PIGF-2) is expressed in human umbilical vein endothelial cells and in placenta. Growth Factors 1993; 9: 259-268.
16. Ziche M, Maglione D, Ribatti D et al. Placenta growth factor-1 is chemotactic, mitogenic, and angiogenic. Lab Invesr 1997; 76: 517-531.
17. Park JE, Chen HH, Winer J, Houck KA, Ferrara N. Placenta growth factor. Potentiation of vascular endothelial growth factor bioactivity, in vitro and vivo, and high affinity binding to Flt-1 but not to Flk1/KDR. J Biol Chem 1994; 269: 25646-25654.
18. Spong CY, Ghidini A, Walker CN, Ossandon M, Pezzullo JC. Elevated maternal serum midtrimester α-fetoprotein levels are associated with fetoplacental ischemia. Am J Obstet Gynecol 1997; 177: 1085-1087.
19. Spong CY, Ghidini A, Sherer DM, Pezzullo JC, Ossandon M, Eglinton GS. Angiogenin: A marker for preterm delivery in midtrimester amniotic fluid. Am J Obstet Gynecol 1997; 176: 415-418.
20. Weiner HL, Weiner LH, Swain JL. Tissue distribution and development expression of the messenger RNA encoding angiogenin. Science 1987; 237: 280-282.
21. Rybak SM, Fett JW, Yao QZ, Vallée BL. Angiogenin mRNA in human tumor and normal cells. Biochem Biophys Res Com 1987; 46: 1240-1248.
22. Kolben M, Bläser J, Ulm K et al. Angiogenin plasma levels during pregnancy. Am J Obsret Gynecol 1997; 176: 37-41.
23. Davey DA, MacGillivray I. The classification and definition of the hypertensive disorders of pregnancy. Am J Obsfef Gynecol 1988; 158: 892-898.
24. Lyall F, Greer IA, Boswell F, Fleming R. Suppression of serum vascular endothelial growth factor immunoreactivity in normal pregnancy and in pre-eclampsia. Br J Obstet Gynaecol 1997; 104: 223-228.
25. Kupferminc MJ, Daniel Y, Englender T et al. Vascular endothelial growth factor in increased in patients with preeclampsia. Am J Reprod Immunol 1997; 38: 302-306.
26. Sharkey AM, Cooper JC, Balmforht JR et al. Maternal plasma levels of vascular endothelial growth factor in normotensive pregnancies and in pregnancies complicated by pre-eclampsia. Eur J Clin Invest 1996; 26 1182-1185.
27. Anthony FW, Evans PW, Wheeler T, Wood PJ. Variations in detection of VEGF in maternal serum by immunoassay and the possible influence of binding proteins. Ann Clin Biochem 1997; 34 276-280.
28. Cooper JC, Sharkey AM, Charnock-Jones DS, Palmer CR, Smith SK. VEGF mRNA levels in placentae from pregnancies complicated by pre-eclampsia. Br J Obstef Gynaecol 1996; 103: 1191-1196.
29. Genbacev O, Zhou Y, Ludlow JW, Fisher SJ. Regulation of human placental development by oxygen tension. Science 1997; 277: 1669-1672.
30. Evans P, Wheeler T, Anthony F, Osmond C. Maternal serum vascular endothelial growth factor during early pregnancy. Clin Sci 1997; 92: 567-571.
31. Wheeler T, Elcock CL, Anthony FW. Angiogenesis and the placental enviroment. Placenta 1995; 16: 289-296.
32. Mohle R, Green D, Moore MAS, Nachman RI, Rafii S. Constitutive production and thrombin-induced release of vascular endothelial growth factor by human megakaryocytes and platelets. Proc Natl Acad Sci USA 1994: 94: 663-668.